Kindred Consolidates Home Health, Grows Revenue

Kindred Healthcare Inc. (NYSE: KND) has reported a year marked by consolidation and significant revenue growth following the fourth quarter of 2015, particularly in its home health division—news that caused Kindred’s share prices to jump about 20% on Friday. During 2015, Kindred at Home, the company’s home health and hospice arm, consolidated its home health […]

Competition Heats Up in Home Health M&A Market

Merger and acquisition activity within the home health sector surged in 2015, and industry professionals predict a robust year ahead, as well. Property valuations may be preventing some major players from completing desired deals, though, and word is that pricing has yet to reach a peak. Months after one of the nation’s largest home health and […]

Gentiva Shareholders Approve Merger With Kindred

Kindred Healthcare, Inc. (NYSE: KND) is nearing the completion of its $1.8 billion merger with Gentiva Health Services, Inc. (NASDAQ: GTIV). Gentiva recently announced the company’s stockholders have approved all necessary proposals for the merger with Kindred, which is expected to be complete Feb. 2, 2015. Kindred and Gentiva entered into a definitive agreement Oct. 9, 2014, […]

Kindred Proposes $1.6 Billion Takeover of Gentiva

A $1.6 billion acquisition could be in the works between two of the home health industry’s largest players as Kindred Healthcare, Inc. (NYSE:KND) sets its sights to acquire Gentiva Health Services, Inc. (NYSE:GTIV).  Under the proposal, Kindred would acquire all of the outstanding shares of common stock of Gentiva for a combination of $7.00 per […]

Gentiva Health Services Promotes David Causby To President, Chief Operating Officer

Gentiva Health Services, Inc. (Nasdaq: GTIV) announced Tuesday that David Causby will assume the role of president and Chief Operating Officer. Causby serves as the company’s Chief Operating Officer and will assume the responsibilities of president consistent with his operating responsibilities. Gentiva Chief Executive Officer Tony Strange said, “David has done a great job in […]

Gentiva Hospice Growth Hampered by Regulatory Pressures

Declining volumes and increasing regulatory pressures took their toll on Gentiva Health Services, Inc. (NASDAQ: GTIV) in 2013. The largest home health and hospice services provider in the United States based on revenue, Gentiva reported a loss attributable to shareholders per diluted share of $18.75 per diluted share for the full-year of 2013.  Total net […]

Gentiva Partners with University Medical Center in New Senior Care Model

National home health and hospice provider Gentiva Health Services (NASDAQ: GTIV) has entered into a joint venture with a North Carolina medical center to provide post-acute senior care following hospital stays. Through a partnership with Wake Forest Baptist Medical Center, the company will operate Wake Forest Baptist Health Care at Home to provide solutions for […]

Gentiva Acquires Harden Healthcare for $409 million

Gentiva Health Services is (NASDAQ: GTIV) further bolstering its position as a home care provider through the $409 million purchase of Harden Healthcare, announced today.  The acquisition will add Harden’s home health, hospice and community care businesses to Gentiva’s portfolio, which the company has grown in recent months to solidify its position in the market […]

Home Health Companies Fall Out of Wall Street Favor Following CMS Proposal

Publicly held home health companies faltered on Wall Street in response to an announcement last week from the Centers for Medicare and Medicaid Services proposing Medicare reimbursements to home health providers will fall 1.5% in 2014, or $290 million based on estimates. Public companies including Gentiva Health Services (NASDAQ: GTIV) and Amedisys Inc. (NASDAQ: AMED) […]

Gentiva Sales Fall 5%, Home Health and Hospice Outlook Remain Strong

Gentiva Health Services, Inc. (NASDAQ: GTIV) today reported total net revenues of $415.6 million, a decrease of 5% compared to $435.7 million for the quarter ended March 31, 2012.  The company also reported a net loss attributable to its shareholders of $207.2 million, or $6.73 per diluted share, for the quarter.  While total net revenues […]